To cite this paper use one of the standards below:
Case presentation: A six-year-old boy, presented in the Emergency Room of a Hospital in Florianópolis (Brazil) with a behavioral arrest and staring eyes that lasted more than two hours and progressed with lowered level of consciousness. He was being treated for an upper respiratory tract infection with symptomatics. Antiepileptic drugs were administered with resolution of the seizures. Brain magnetic resonance imaging (MRI) performed was compatible with Acute Disseminated Encephalomyelitis (ADEM). He was treated with intravenous methylprednisolone exhibiting great recovery. A control MRI after three months of the hospitalization showed many white matter lesions and some of them with enhancement, consistent with MS. Patient was asymptomatic during this period. The test for MOG autoantibody was negative. The boy was diagnosed with possible MS and started on Interferon Beta. After three years, the boy maintains an EDSS of zero, although MRI shows that he continues to accumulate new brain lesions. Therefore, it is thought when the boy becomes older to change to a more effective drug.
Discussion: ADEM is a rare initial presentation of MS, especially if compared to other demyelinating diseases, in this way, it is important to exclude alternative diagnosis. Considering that in this case, the McDonald criteria shouldn’t be applied and the kid hasn't had other non-ADEM attacks to fulfill the criteria. Nevertheless, the child has juxtacortical, periventricular and infratentorial lesions on MRI and in follow-up images shows enhancement of certain lesions. It was decided to initiate treatment, despite completing diagnostic criteria for MS, since it is a highly active disease with lesions that can aggregate disability in the future, even with no clinical relapse.
Final comments:This case-report is a reminder that ADEM may be a first presentation of MS and it could be suspected, mostly, by MRI pattern.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper